Back
Enanta Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
ENTA
Enanta Pharmaceuticals
Last Price:
9.30
Seasonality Move:
15.66%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
Enanta Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.96 | Sell |
| 20-day SMA: | 10.83 | Sell |
| 50-day SMA: | 11.2 | Sell |
| 200-day SMA: | 13.06 | Sell |
| 8-day EMA: | 9.87 | Sell |
| 20-day EMA: | 10.57 | Sell |
| 50-day EMA: | 11.25 | Sell |
| 200-day EMA: | 13.17 | Sell |
Enanta Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 23.87 | Sell |
| Chaikin Money Flow: | -81245 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.14 - 12.24) | Sell |
| Bollinger Bands (100): | (10.76 - 14.02) | Sell |
Enanta Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enanta Pharmaceuticals Stock
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 9.08 while ENTA 8-day simple moving average is 9.96, which is a Sell signal.
- The stock price of ENTA is 9.08 while Enanta Pharmaceuticals 20-day SMA is 10.83, which makes it a Sell.
- Enanta Pharmaceuticals 50-day simple moving average is 11.20 while ENTA share price is 9.08, making it a Sell technically.
- ENTA stock price is 9.08 and Enanta Pharmaceuticals 200-day simple moving average is 13.06, creating a Sell signal.
ENTA Technical Analysis vs Fundamental Analysis
Sell
25
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a Sell
The current Enanta Pharmaceuticals [ENTA] share price is $9.08. The Score for ENTA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Enanta Pharmaceuticals Stock Info
Market Cap:
192.39M
Price in USD:
9.08
Share Volume:
158.74K
Enanta Pharmaceuticals 52-Week Range
52-Week High:
17.80
52-Week Low:
8.51
Sell
25
Enanta Pharmaceuticals (ENTA)
is a Sell
Enanta Pharmaceuticals Share Price Forecast
-
What is the Enanta Pharmaceuticals stock price today?
The Enanta Pharmaceuticals stock price is 9.08 USD today. -
Will ENTA stock go up or go down?
Enanta Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Enanta Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals is overvalued.
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 9.08 while ENTA 8-day exponential moving average is 9.87, which is a Sell signal.
- The stock price of ENTA is 9.08 while Enanta Pharmaceuticals 20-day EMA is 10.57, which makes it a Sell.
- Enanta Pharmaceuticals 50-day exponential moving average is 11.25 while ENTA share price is 9.08, making it a Sell technically.
- ENTA stock price is 9.08 and Enanta Pharmaceuticals 200-day simple moving average is 13.17, creating a Sell signal.
Fundamental Analysis of Enanta Pharmaceuticals
Is Enanta Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.01 per share, and an increase next year of $0.23 per share.
Technical Analysis of Enanta Pharmaceuticals
Should I short Enanta Pharmaceuticals stock?
- ENTA Moving Average Covergence Divergence (MACD) indicator is -0.58, suggesting Enanta Pharmaceuticals is a Sell
- Enanta Pharmaceuticals Relative Strength Index (RSI) is 23.87, which suggest Enanta Pharmaceuticals is oversold
- The Bollinger Bands (25) for Enanta Pharmaceuticals is (10.14 - 12.24), which suggest Enanta Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Enanta Pharmaceuticals is (10.76 - 14.02), which suggest Enanta Pharmaceuticals is a Sell
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.